Background/Aims: Accumulated evidence indicates that lncRNA NEAT1 has important roles in various malignant tumors. NEAT1 Methods: The effects of NEAT1 on cell proliferation, apoptosis, migration, and invasion were measured by in vitro NEAT1
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Introduction
Primary liver cancer is the sixth most common malignancy worldwide and the second leading cause of cancer mortality, accounting for an estimated 40, 710 diagnoses and 28, 920 deaths in 2017 [1] . In most countries, hepatocellular carcinoma (HCC) represents the traditional surgery to more effective therapies, such as liver transplantation, chemotherapy, radiotherapy, and thermotherapy, the survival rates for HCC are unfortunately poor owing to the high invasive ability of HCC cells [2] . Therefore, it is urgent to explore the genetic mechanisms of HCC and to search for personalized treatment options.
Long non-coding RNAs (lncRNAs), which contain more than 200 nucleotides [3] , have gradually become a large research focus in recent years. It has been shown that lncRNAs play essential roles in maintaining cellular homeostasis during cell development and are vital elements in the pathophysiology of cancer [3] [4] [5] [6] [7] [8] . A growing number of studies have shown that many lncRNAs are associated with HCC. For example, Panzitt et al. [9] found that the upregulation of lncRNA HULC could downregulate tumor suppressor gene P18 and thus promote HCC cell growth. Sui et al. [10] reported that lncRNA linc-USP16 may negatively regulate migration and invasion of HCC cells by regulating PTEN expression. Wang et al.
[11] demonstrated that lncRNA UCA1 inhibited the malignant behavior of HCC cells through downregulation of miR-216 and activation of the FGFR1/ERK pathway. However, there are still numerous novel lncRNAs that remain uncharacterized.
Nuclear paraspeckle assembly transcript 1 (NEAT1), a structural component of paraspeckles, consists of two variants: 3.7-kb NEAT1_v1 ( ) and 23-kb NEAT1_v2 ( ) [12, 13] . Some investigators have demonstrated that NEAT1 plays essential roles in several malignancies, including breast cancer, lung cancer, laryngeal squamous cell cancer, gastric cancer, nasopharyngeal carcinoma, pancreatic carcinoma, and colorectal cancer [14] [15] [16] [17] [18] [19] [20] . Our research group previously conducted a comprehensive analysis of the clinical value of NEAT1 in digestive system malignancies based on 57 microarray and RNA-seq datasets, ultimately NEAT1 may play different roles in the initiation and progression of digestive system cancers [21] . The biological functions of NEAT1 in HCC have also been investigated in previous studies. A study conducted by Mang et al. [22] showed that NEAT1 stimulated the proliferation and invasion of HCC cells in vitro. Wang et al. [23] also found that NEAT1 could boost cell invasion and proliferation in HCC through inhibition of miR-613 expression.
In this study, we not only studied the biological effects of NEAT1 on HCC cells in vitro but also systematically analyzed the expression level and clinical NEAT1 in HCC based on RNA-seq and microarray datasets from The Cancer Genome Atlas (TCGA) and Oncomine databases. Additionally, real-time quantitative PCR (RT-qPCR) was conducted to verify the expression of NEAT1. Furthermore, we analyzed the genes coexpressed with NEAT1 according to Gene Ontology (GO) functional annotation and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses. A protein-protein interaction (PPI) network was also constructed. The overall design of the present study is shown in Fig. 1 .
Data mining from TCGA and Oncomine
Based on the following criteria, lncRNA sequencing and microarray datasets available up to August 28, 2017 were downloaded from TCGA [28] and Oncomine [29] : (1) both HCC and normal control tissues were included in the study, and each group included more than two samples; (2) the expression data of NEAT1 was provided directly or could be calculated; and (3) the species was human.
author, publication year, region, data source, sample size, and NEAT1 expression (mean ± SD) in HCC and normal control groups. All disagreements were resolved by discussion with a third (G.C.) and fourth (R.-L.L.) investigator.
assess the pooled expression level of NEAT1 in HCC. A summary receiver operating characteristic (SROC) ability of NEAT1 in discriminating HCC patients from normal controls. Begg's and Egger's tests were applied to estimate publication bias [30] . All analyses were carried out using STATA 12.0 (Stata Corporation, College Station, TX). The P
The relationships between NEAT1 expression and the clinicopathological factors and prognoses were estimated with data from the TCGA. An independent sample t-test was employed to assess the relationships between NEAT1 expression and the clinicopathological parameters. All HCC patients were divided into lowexpression and high-expression groups according to the median expression value of NEAT1. Then, a KaplanMeier survival curve with a log-rank test was applied to evaluate the prognostic value of NEAT1 in HCC.
was an independent prognostic biomarker.
Bioinformatics analysis of NEAT1 co-expressed genes
The genes co-expressed with NEAT1 were collected from the cBioPortal website [31] . GO functional annotation and KEGG pathway analyses were performed with the DAVID online tool [32] . We selected coexpressed genes that participated in cancer-related pathways to construct a PPI network using the STRING online database [33] . Then, we selected genes that interacted in the PPI network for further analysis. Independent sample t-tests were applied to evaluate the expression levels of these selected genes using expression data from TCGA. A Pearson correlation analysis was employed to assess the associations between the selected genes and NEAT1.
Results
Biological effects of NEAT1 on HCC cells in vitro NEAT1 siRNA inhibited proliferation of HCC cells
In this study, NEAT1 siRNA effectively decreased NEAT1 expression in HepG2 and showing a time-independent inhibitory effect of NEAT1 siRNA on the proliferation of HepG2 viability assay revealed that the viability of cells transfected with NEAT1 siRNA was markedly decreased compared with those cells transfected with the mock control.
NEAT1 siRNA induced apoptosis of HCC cells
Whether NEAT1 staining analyses were conducted. Caspase-3/7 activity and apoptosis were remarkably increased in HCC cells with NEAT1 siRNA transfection (Fig. 3A, B, C, D) . In addition, viable Hoechst 33342/PI staining for 96 h. The result showed that NEAT1 boosted HCC cell apoptosis and decreased cell viability (Fig. 3E) . 
NEAT1 siRNA suppressed migration and invasion of HCC cells
The effect of NEAT1 on cell migration and invasion was examined in HepB3 cells using wound-healing and Transwell assays. NEAT1 wound-healing rate and invasiveness of the HepB3 cells compared with the blank control (Fig. 4) .
Expression level and clinical
Expression level of NEAT1 in HCC A total of four records containing 574 HCC samples and 174 non-cancerous specimens were included in our study, and the key information on the four records is presented in Table 1 .
The expression level of NEAT1 in each included dataset was visualized using scatter plots and receiver operating characteristic curves (Fig. 5 ). Owing to the low reliability of individual studies, we combined the four records to obtain a stronger result. The pooled (I 2 = 37.7%; P = 0.186) indicated that NEAT1 was upregulated in HCC (SMD, 0.54; 95% CI, 0.36-0.73; P < NEAT1 expression data and corresponding clinical and survival information were obtained from TCGA. Our results revealed that NEAT1 P = 0.025; Fig. 7A ) and distant metastasis (P = 0.002; Fig. 7B ) but not related to gender, age, clinical TNM stage, histological grade, lymph node metastasis, or vascular invasion (Table 2) . A Kaplan-Meier survival curve was generated to gain insight into the prognostic role of NEAT1 in HCC. The results revealed that high NEAT1 expression indicated higher overall survival (OS; P NEAT1 expression and disease-free survival (P = 0.257; Fig. 7D ). Then, we further performed univariate and multivariate Cox regression analyses to evaluate the effect of NEAT1 expression on OS (Table  3 ). The hazard ratio (HR) from the univariate Cox regression analysis indicated that NEAT1 P = 0.029). More importantly, the multivariate Cox regression analysis showed that NEAT1 was still associated with OS (HR, 0.568; 95% CI, 0.329-0.98; P = 0.042) after adjusting for age, race, gender, histological grade, stage, lymph node metastasis, distant metastasis, and vascular invasion, which suggests that NEAT1 is an independent prognostic biomarker for patients with HCC. functional annotations and KEGG pathways are presented in Fig. 9 . The result of the KEGG pathway analysis revealed that the co-expressed genes are involved in several cancer-related pathways, such as "viral carcinogenesis", "transcriptional mis-regulation in cancer" and "P53 signaling pathway".
Construction of the PPI network
In total, 21 genes related to "viral carcinogenesis", "transcriptional mis-regulation in cancer" and "P53 signaling pathway" were selected to construct a PPI network (Fig. 10) . A these genes. We found interactions among the following 14 genes: MDM2 (mouse double minute 2), SP1 (transcription MDM4 (mouse double minute 4), ATM (ATM serine/threonine kinase), CREBBP (cyclic AMP responsive element-binding protein), PMAIP1 (phorbol-12-myristate-13-acetate-induced protein 1), TRAF5 (TNF receptor associated factor 5), SERPINB5 (serpin family B member 5), CASP8 (caspase 8), TRAF1 (TNF receptor associated factor 1), KAT2A (lysine acetyltransferase 2A), HIST4H4 (histone cluster 4 H4 ), HIST1H2BF (histone cluster 1 H2B family member f) and HIST1H4E (histone cluster 1 H4 family member e). Then, we evaluated the expression levels of the 14 genes involved in HCC and further investigated how their expression was correlated with that of NEAT1. Because the expression levels of the genes SERPINB5, HIST1H2BF, and Fig. 13) . Additionally, the expression patterns of the proteins encoded by these eight genes were validated based on the Human Protein Atlas database (http://www. proteinatlas.org/), and the results are displayed in Fig. 14 . Our results indicate that NEAT1 may exert its unique role in HCC through interactions with these eight genes.
Discussion
With the innovation of genomic and molecular technologies, the functions of lncRNAs in various cancers have received increasing attention in recent years. Accordingly, lncRNAs have been revealed to perform complicated roles in carcinogenesis and cancer progression at the chromatin organizational, translational, and post-translational levels [34] . NEAT1, a lncRNA that participates in the formation of the paraspeckle, has also been demonstrated to be involved in the occurrence and development of many malignancies. Peng et al. [35] detected the expression of NEAT1 in 56 colorectal cancer (CRC) and adjacent noncancerous tissues and found that NEAT1 was upregulated in CRC tissues. The authors found that knockdown of NEAT1 cell apoptosis, indicating that NEAT1 may act as an oncogene in CRC. However, Idogawa et al. [36] silenced NEAT1 by transferring NEAT1 cancer A549 cells and discovered that NEAT1 knockdown could promote cell growth, which suggested that NEAT1 may be a tumor suppressor. The effect of NEAT1 on HCC has been explored in previous studies. Fujimoto et al.
[37] pursued a characterization of noncoding mutations in liver cancer and found that NEAT1 mutations in liver cancer, which may cause aberrant expression of NEAT1 in liver cancer. Then, the authors silenced NEAT1 expression in HepG2 cells and found that the inhibition of NEAT1 A study conducted by Mang et al. [22] showed that knockdown of NEAT1 inhibited the proliferation and invasion of HCC HepG2 and SMMC-7721 cells. A study performed by Wang et al. [23] also demonstrated that silencing NEAT1 in vitro could obviously arrest HCC cell proliferation and invasion. However, the effect of NEATI on HCC cell apoptosis has not been explored to date. In the present study, we detected the effects of NEAT1 on proliferation, apoptosis, migration, and invasion of HCC cells by transfecting NEAT1 siRNA into HepB3 and/or HepG2 cells. Our results indicate NEAT1 siRNA observably inhibits proliferation, migration, and invasion of HCC cells, which was consistent with previous studies [22, 23, 38] . More importantly, we also found that NEAT1 NEAT1 may promote tumor deterioration in HCC.
To further probe the exact role of NEAT1 in HCC, we obtained relevant RNA-seq and microarray datasets. Our research group has previously performed a comprehensive analysis of the expression levels of NEAT1 in digestive system malignancies based on data from TCGA, GEO, ArrayExpress, and Oncomine [21] . The combined result based on 13 RNA-seq and microarray datasets showed that NEAT1 was downregulated in HCC. However, the result should be interpreted cautiously because a remarkable heterogeneity exists, which may heterogeneity on our result, we only included RNA-seq and microarray datasets from TCGA and Oncomine. Additionally, we performed RT-qPCR to validate the expression of NEAT1. Then, a combined strategy using RNA-seq, gene chip, and RT-qPCR data was employed to systematically investigate the expression levels of NEAT1 in HCC. We found that NEAT1 was Compared with those previous studies, our present study included more cases.
A study conducted by Li et al. [39] showed that overexpression of NEAT1 could drive endometrial adenocarcinoma (EAC) cells in the S phase and thus boost tumor cell proliferation. Additionally, the overexpression of NEAT1 in EAC cells could upregulate metastasis-related genes, such as matrix metallopeptidase 7 (MMP-7), MMP-2, insulin-like growth factor 1, and c-myc. In the present study, we also found that high NEAT1 expression was related to metastasis of HCC. We hypothesize that NEAT1 facilitates HCC metastasis by regulating some metastasis-related genes. Further studies are needed to validate our conjecture.
The prognostic value of NEAT1 in HCC was also assessed in this study. The results indicated that high NEAT1 expression was closely associated with better overall survival and could serve as an independent prognostic factor for predicting the prognosis of patients with HCC. A study conducted by Idogawa et al. [36] based on microarray datasets from GEO also showed that the survival rate was higher among cancer patients with high NEAT1 expression relative to patients with low NEAT1 expression. The authors analyzed chromatin immunoprecipitation-sequencing data and found that NEAT1 was a transcriptional target of tumor suppressor P53 and that overexpressed NEAT1 could enhance the tumor suppressor effect of P53. Therefore, patients with high expression of NEAT1 have a favorable survival To preliminarily explore the molecular mechanism of NEAT1 in HCC, we performed GO and KEGG pathway analyses on 1, 250 genes coexpressed with NEAT1 from cBioPortal, a public database that collects and processes data from TCGA. We found that these co-expressed genes were involved in some cancer-related pathways, such as "regulation of transcription", "transcriptional mis-regulation in cancer" and "P53 signaling pathway". Then we selected 21 genes that participated in the above three pathways to construct a PPI network. Among the 21 co-expressed genes, 14 genes were shown to interact with each other. The expression levels of the 14 genes and the correlations between them and NEAT1 were further evaluated. We found that the genes SP1, MDM4, CREBBP, TRAF5, CASP8, TRAF1, KAT2A, and HIST4H4 were not only upregulated in HCC but also closely linked with NEAT1, indicating that NEAT1 may promote HCC carcinogenesis by interacting with these eight genes.
Accumulated data have demonstrated that the overexpression of CREBBP, SP1, and MDM4 play central roles in various malignant tumors including HCC. Servillo et al. [41] found that CREBBP increased hepatocyte proliferation. Abramovitch et al. [42] demonstrated that CREBBP could promote HCC progression by stimulating tumor cell growth and reducing cell apoptosis in vitro and in vivo. upregulated lncRNA MALAT1 in HCC and further activated tumor progression. Gandhy et al. [44] proposed that SP1 promoted tumor cell proliferation and migration by increasing the expression of lncRNA HULC in HCC. MADM4, a P53 binding protein homolog, is a critical negative modulator of tumor suppressor P53 [45] . Pellegrino et al [46] showed that MDM4 . acted as an oncogene in HCC by interacting with the PI3K-AKT/mTOR pathways. The authors also demonstrated that reducing the expression level of MDM4 by inhibiting the PI3K/AKT/ mTOR pathways could reactivate tumor inhibition by P53 and subsequently inhibit the progression of HCC.
Both KAT2A and HIST4H4 play central roles in transcriptional regulation and have been demonstrated to exert roles in gastric carcinoma [47, 48] . However, their biological functions in HCC have not yet been studied. Accordingly, further in vitro and in vivo experiments are necessary to uncover the exact roles of KAT2A and HIST4H4 in HCC.
TRAF1, TRAF5, and CASP8 are apoptosis-related genes [49] . TRAF1 and TRAF5 are members of the TRAF family that have been shown to participate in cell apoptosis by Previous studies have shown that TRAF1 and TRAF5 are related to various malignancies including HCC [53, 54] . CASP8, an extremely critical molecule in the caspase-dependent proteinase (caspase) family. The caspase family contains many well-known apoptosis-related proteinases, such as CASP2, CASP3, CASP6, CASP7, CASP8, CASP9, CASP10, and CASP11, which play key roles in cell apoptosis. A large number of studies have provided evidence that these caspases are involved in the occurrence and progression of HCC [55] [56] [57] [58] [59] . However, the relationships between these caspases and NEAT1 have not yet been investigated. In the NEAT1 siRNA could induce HCC cells to undergo apoptosis in vitro. We hypothesize that NEAT1 inhibits apoptosis of HCC cells by interacting with these apoptosis-related genes. Further and stricter in vitro and in vivo investigations are needed to Our comprehensive analyses of in vitro experiments as well as RNA-seq and microarray datasets and in-house RT-qPCR suggest that NEAT1 could promote the deterioration of HCC. More importantly, NEAT1 could serve as a diagnostic and prognostic biomarker that provides a new perspective for molecular-targeted treatment of HCC in clinical settings.
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